In vitro and in vivo characterization of the activity of telmisartan: An insurmountable angiotensin II receptor antagonist

Journal of Pharmacology and Experimental Therapeutics

Volumn 302, Issue 3, 2002, Pages 1089-1095

  Maillard, Marc P ^a   Perregaux, Christine ^b   Centeno, Catherine ^b   Stangier, Joachim ^a   Wienen, Wolfgang ^a   Brunner, Hans R ^b   Burnier, Michel ^b  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 2 RECEPTOR; CANDESARTAN; IRBESARTAN; RECEPTOR SUBTYPE; TELMISARTAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE; DISSOCIATION; DISSOCIATION CONSTANT; DOSE RESPONSE; DRUG ACTIVITY; DRUG BINDING; DRUG BLOOD LEVEL; DRUG POTENCY; HALF LIFE TIME; MALE; NONHUMAN; PRESSOR RESPONSE; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

ANGIOTENSIN II; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; AORTA, THORACIC; BENZIMIDAZOLES; BENZOATES; BIPHENYL COMPOUNDS; BLOOD PRESSURE; CELL MEMBRANE; KINETICS; MUSCLE, SMOOTH, VASCULAR; RADIOLIGAND ASSAY; RATS; RATS, WISTAR; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTORS, ANGIOTENSIN; TETRAZOLES;

EID: 0036720461     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.102.036772     Document Type: Article

References (32)

1. Angiotensin II receptor antagonists
2. Effect of endotoxin on the angiotensin II receptor in cultured vascular smooth muscle cells
3. Pharmacological characterization of SR 47436, a new nonpeptide AT1 subtype angiotensin II receptor antagonist
4. Oral administration of DuP753, a specific angiotensin II receptor antagonist, to normal volunteers
5. Disposition of irbesartan, an angiotensin II AT1 receptor antagonist, in mice, rats, rabbits, and macaques
6. The serotonin S-2 receptor: A receptor-transducer coupling model to explain insurmountable effects
7. 3H]candesartan to angiotensin II AT1 receptor-transfected Chinese hamster ovary cells
8. Insurmountable angiotensin AT1 receptor antagonists: The role of tight antagonist binding
9. Effect of SR 47436, a novel angiotensin II AT1 receptor antagonist, on human vascular smooth muscle cells in vitro
10. The possible effects of the aggregation of the molecules of hemoglobin on its dissociation curves
11. Disposition of the new angiotensin II receptor antagonist candesartan cilexetil in rats and dogs
12. Evidence that the apparent complexity of receptor antagonism by angiotensin II analogues is due to a reversible and syntopic action
13. Does protein binding modulate the effect of angiotensin II receptor antagonists?
14. Assessment of angiotensin II receptor blockade in humans using an in vitro binding assay: Comparison with the in vivo approach
15. Tasosartan, enoltasosartan and angiotensin II receptor blockade, the confounding role of protein binding
16. Pharmacological profile of UR-7247, an orally active angiotensin II receptor antagionist in healthy volunteers
17. Comparative angiotensin II receptor blockade in healthy volunteers: The importance of dosing
18. Angiotensin II receptor blockade in normotensive subjects: A direct comparison of three AT1 receptor antagonists
19. Pharmacological properties of KT3-671, a novel nonpeptide angiotensin II receptor antagonist
20. Mechanistic differences of various AT-1 receptor blockers in isolated vessels of different origin
21. Candesartan (CV-11974) dissociates slowly from the angiotensin AT1 receptor
22. Functional studies but not receptor binding can distinguish surmountable from insurmountable AT1 antagonism
23. Agonistantagonist interactions at angiotensin-receptor: Application of a two-state receptor model
24. Differentiation between binding sites for angiotensin II and non-peptide antagonists on the angiotensin II type 1 receptor
25. Angiotensin II receptor antagonists: An emerging new class of cardiovascular therapeutics
26. Nonpeptide angiotensin II receptor antagonists
27. Angiotensin II receptors and angiotensin II receptor antagonists
28. 1A receptors
29. Reversible and syntopic interaction between angiotensin receptor antagonists on Chinese hamster ovary cells expressing human angiotensin II type 1 receptors
30. Angiotensin II type 1 receptor antagonists. Why do some of them produce insurmountable inhibition?
31. Pharmacological characterization of the novel nonpeptide angiotensin II receptor antagonist, BIBR 277
32. Different types of receptor interaction of peptide and nonpeptide angiotensin II antagonists revealed by receptor binding and functional studies